Search Results

LY 2874455 50mg 50mg  | Purity Not Available

Adooq Bioscience

LY2874455 is a novel and potent FGF/FGFR Inhibitor.

More Information Supplier Page

×

LY 2874455 50mg

LY 2874455 5mg 5mg  | Purity Not Available

Adooq Bioscience

LY2874455 is a novel and potent FGF/FGFR Inhibitor.

More Information Supplier Page

×

LY 2874455 5mg

LY 2874455 25mg 25mg  | Purity Not Available

Adooq Bioscience

LY2874455 is a novel and potent FGF/FGFR Inhibitor.

More Information Supplier Page

×

LY 2874455 25mg

LY 2874455 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

LY2874455 is a novel and potent FGF/FGFR Inhibitor.

More Information Supplier Page

×

LY 2874455 10mM * 1mL in DMSO

TAK-438 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

TAK-438 is a novel potassium-competitive acid blocker.

More Information Supplier Page

×

TAK-438 10mM * 1mL in DMSO

TAK-438 10mg 10mg  | Purity Not Available

Adooq Bioscience

TAK-438 is a novel potassium-competitive acid blocker.

More Information Supplier Page

×

TAK-438 10mg

Ticagrelor 25mg 25mg  | Purity Not Available

Adooq Bioscience

Ticagrelor (AZD6140) is the first reversibly binding oral P2Y(12) receptor antagonist that blocks ADP-induced platelet aggregation.

More Information Supplier Page

×

Ticagrelor 25mg

FG-4592 50mg 50mg  | Purity Not Available

Adooq Bioscience

FG-4592 is a novel hypoxia inducible factor prolyl hydroxylase inhibitor, in CKD anemia.

More Information Supplier Page

×

FG-4592 50mg

FG-4592 25mg 25mg  | Purity Not Available

Adooq Bioscience

FG-4592 is a novel hypoxia inducible factor prolyl hydroxylase inhibitor, in CKD anemia.

More Information Supplier Page

×

FG-4592 25mg

FG-4592 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

FG-4592 is a novel hypoxia inducible factor prolyl hydroxylase inhibitor, in CKD anemia.

More Information Supplier Page

×

FG-4592 10mM * 1mL in DMSO